Search research articles
Contact Us
Filters
Showing results (41-50 of 123) with videos related to
Page
of 13
Sort By:
The Journal of Infectious Diseases
|
July 25, 2024
Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zahra R Tehrani, Parham Habibzadeh, Robin Flinko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma
Joseph D Khoury, L Jeffrey Medeiros, George Z Rassidakis, et al.
American Journal of Hematology
|
April 2, 2020
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma
Firas El Chaer, Ariel Siegel, Noa G Holtzman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 3, 2020
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation
Gabriela Sanchez-Petitto, Noa G Holtzman, Ali Bukhari, et al.
Journal of Infection and Public Health
|
September 14, 2013
Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations
Hail M Al-Abdely, Adel F Alothman, Jameela Al Salman, et al.
Bone Marrow Transplantation
|
February 2, 2016
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
J A Yared, N Hardy, Z Singh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2025
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant
David T Chen, Olga Goloubeva, Aaron P Rapoport, et al.
American Journal of Hematology
|
October 18, 2018
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab
Firas El Chaer, Omer M Ali, Edward A Sausville, et al.
Transplantation and Cellular Therapy
|
June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell Therapy
Hanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Blood Advances
|
April 9, 2024
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients
Sanjeet S Dadwal, Rajat Bansal, Michael W Schuster, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 123) with videos related to
Sort By:
Page
of 13
The Journal of Infectious Diseases
|
July 25, 2024
Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zahra R Tehrani, Parham Habibzadeh, Robin Flinko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma
Joseph D Khoury, L Jeffrey Medeiros, George Z Rassidakis, et al.
American Journal of Hematology
|
April 2, 2020
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma
Firas El Chaer, Ariel Siegel, Noa G Holtzman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 3, 2020
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation
Gabriela Sanchez-Petitto, Noa G Holtzman, Ali Bukhari, et al.
Journal of Infection and Public Health
|
September 14, 2013
Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations
Hail M Al-Abdely, Adel F Alothman, Jameela Al Salman, et al.
Bone Marrow Transplantation
|
February 2, 2016
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
J A Yared, N Hardy, Z Singh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2025
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant
David T Chen, Olga Goloubeva, Aaron P Rapoport, et al.
American Journal of Hematology
|
October 18, 2018
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab
Firas El Chaer, Omer M Ali, Edward A Sausville, et al.
Transplantation and Cellular Therapy
|
June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell Therapy
Hanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Blood Advances
|
April 9, 2024
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients
Sanjeet S Dadwal, Rajat Bansal, Michael W Schuster, et al.
Page
of 13